InvestorsObserver
×
News Home

Should You Add Khiron Life Sciences Corp (KHRNF) Stock to Your Portfolio Thursday?

Thursday, March 23, 2023 03:41 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Khiron Life Sciences Corp (KHRNF) Stock to Your Portfolio Thursday?

Khiron Life Sciences Corp (KHRNF) is near the bottom in its sector according to InvestorsObserver. KHRNF gets an overall rating of 34. That means it scores higher than 34% of stocks. Khiron Life Sciences Corp gets a 17 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 34
KHRNF has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on KHRNF!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 34 means the stock is more attractive than 34 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Khiron Life Sciences Corp Stock Today?

Khiron Life Sciences Corp (KHRNF) stock is trading at $0.04 as of 3:19 PM on Thursday, Mar 23, a decline of $0.00, or -2.22% from the previous closing price of $0.05. The stock has traded between $0.04 and $0.05 so far today. Volume today is elevated. So far 249,046 shares have traded compared to average volume of 179,954 shares. Click Here to get the full Stock Report for Khiron Life Sciences Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App